Published in AIDS Weekly, February 24th, 2003
Tomas Hanke and colleagues at the Weatherall Institute of Molecular Medicine in Oxford, England, and the Karolinska Institutet in Stockholm, Sweden, described their "experimental subunit" vaccine, dubbed SFV.HIVA.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.